News > masslifesciences.com - Posted Sep 28, 2016 /By Angus McQuilken, MLSC Vice President for Marketing & Communications
ABI-LAB Celebrates its Grand Opening in Natick Massachusetts
ABI-LAB is a state-of-the art 10,000 square-foot Differentiated Accelerator and Bio-Incubator
Natick, MA – Wednesday, September 28, 2016 – CEO of Karyopharm Therapeutics Inc., Dr. Michael Kauffman, joined by State Senator Karen Spilka, State Senator Richard Ross, State Representative David Linsky, Paul Joseph, President & CEO of the Metrowest Chamber of Commerce, and Angus McQuilken, Vice President for Communications & Marketing for the Massachusetts Life Science Center (MLSC) - along with representative from MassBio, founders, resident companies, and friends, celebrated the grand opening of ABI-LAB in Natick Massachusetts today.
"We founded ABI-LAB because there was a need for affordable lab space in the biotech industry" said Dr. Rafael Nir, Managing Partner of ABI-LAB. "With high lab costs around the commonwealth and the struggle that new start-ups face it was a natural endeavor that Gary Kaufman, Managing Partner of ABI-LAB, and I wanted to embark on."
ABI-LAB offers open-lab and office space for up to 10 start-up companies. ABI-LAB provides flexible lab space, a collaborative atmosphere, mentoring for start-ups, networking opportunities, and contract lab services which include protein production, cell-culture, cell-based assays, biomarker analysis and animal studies (oncology and NASH models). ABI-LAB is planning to expand and add 8 additional suites, lab and office space by January 2017.
"ABI-LAB is not only just lab space that has dedicated and shared labs," said Kaufman. "It is a facility that encourages and fosters collaboration between companies. We pride
ourselves on helping companies find funding from investors. ABI-LAB is always
searching for companies that have a promising future so we may help fund them. Our
onsite services that SBH can provide will help many of our residents bring products to
the market faster."
"The biotech sector is thriving in Massachusetts, and ABI-LAB's incubator space will allow more innovative biotech entrepreneurs to grow and thrive here in MetroWest," said Senator Karen E. Spilka (D-Ashland). "I look forward to continuing to work with
MassBio, the Massachusetts Life Sciences Center and ABI LAB to advance our local
life sciences workforce and innovation economy."
"The ABI-LAB provides a tremendous opportunity for collaborative and innovative work
in the biotech industry," said Representative David P. Linsky (D-Natick). "I am happy
that their facility will be in Natick and I am looking forward to the research that will take
place there, which will not only benefit the Commonwealth but the biotech industry as a
"ABI-LAB will provide much-needed space for promising early-stage companies with
potential for growth and future job creation," said Massachusetts Assistant Secretary for
Economic Development Mike Kennealy. "This new facility is joining a community of
more than two dozen incubators across the state that are an essential part of our life
"ABI-LAB is a great addition to the life sciences infrastructure in the MetroWest region," said Travis McCready, President & CEO of the Massachusetts Life Sciences Center. "Life sciences incubators like ABI-LAB provide entrepreneurs with the space, services,
equipment and expertise needed to start a company at a fraction of the cost it would
take to set up their own lab. The addition of this space in Natick helps reinforce that
every region of Massachusetts has a role to play in our life sciences ecosystem."
ABI-LAB is a state-of-the art 10,000 square-foot (soon to be 17,000 square-feet)
Differentiated Accelerator and Bio-Incubator located in Natick, Massachusetts. ABI-LAB
provides affordable lab space to 7 biotech companies and will be home to over 15
companies as phase two of the building is completed in January 2017. www.ABILAB.
About the Massachusetts Life Science Center
The Massachusetts Life Sciences Center (MLSC) is a quasi-public agency of the
Commonwealth of Massachusetts tasked with implementing the Massachusetts Life
Sciences Act, a $1-billion initiative that was signed into law in June of 2008. The
MLSC's mission is to create jobs in the life sciences – biotechnology, pharmaceuticals,
medical devices, diagnostics and bioinformatics — and support vital scientific research
that will improve the human condition. This work includes making financial investments
in public and private institutions that are advancing life sciences research, development and commercialization as well as building ties among sectors of the Massachusetts life sciences community. www.masslifesciences.com